Clinical Trial Update: Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas [Phase 4]

View source ↗

Summary

This is an update on a Phase 4 clinical trial evaluating a multi-agent chemotherapy regimen (cisplatin, ifosfamide, gemcitabine, L-asparaginase, etoposide, and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• CISPLATIN (cisplatin)
• DEXAMETHASONE (Dexamethasone)
• Etoposide (Etoposide)
• Gemcitabine (Gemcitabine)
• IFOSFAMIDE (IFOSFAMIDE)
• L-asparaginase (L-asparaginase)

Snippet

Sponsor: The University of Hong Kong | Conditions: Peripheral T Cell Lymphoma | Phase 4 | Status: UNKNOWN